The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma

por Yu, Liang-He, Li, Nan, Cheng, Shu-Qun
Publicado 2011

Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Letter]

por Feng, Jin-Kai, Sun, Ju-Xian, Liu, Zong-Han, Cheng, Shu-Qun
Publicado 2021

Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection

por Qi, Peng, Cheng, Shu-qun, Wang, Hao, Li, Nan, Chen, Yue-feng, Gao, Chun-fang
Publicado 2011

The Intracellular HBV DNAs as Novel and Sensitive Biomarkers for the Clinical Diagnosis of Occult HBV Infection in HBeAg Negative Hepatocellular Carcinoma in China

por Wang, Hui, Fang, Meng, Gu, Xing, Ji, Qiang, Li, Dongdi, Cheng, Shu-Qun, Shen, Feng, Gao, Chun-Fang
Publicado 2014

Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

por Zhang, XiuPing, Wang, Kang, Wang, Meng, Yang, Guang, Ye, XiaoFei, Wu, MengChao, Cheng, ShuQun
Publicado 2017

Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence

por Jiang, Yu, Wang, Kang, Wang, Yu-Ran, Xiang, Yan-Jun, Liu, Zong-Han, Feng, Jin-Kai, Cheng, Shu-Qun
Publicado 2023

Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma

por Sun, Ju-Xian, Shi, Jie, Li, Nan, Guo, Wei-Xing, Wu, Meng-Chao, Lau, Wan-Yee, Cheng, Shu-Qun
Publicado 2016

Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an exter...

por Ye, Jia-zhou, Mai, Rong-yun, Guo, Wei-xing, Wang, Yan-yan, Ma, Liang, Xiang, Bang-de, Cheng, Shu-qun, Li, Le-qun
Publicado 2020

Prognostic Value of Microvascular Invasion in Eight Existing Staging Systems for Hepatocellular Carcinoma: A Bi-Centeric Retrospective Cohort Study

por Xiang, Yan-Jun, Wang, Kang, Zheng, Yi-Tao, Yu, Hong-Ming, Cheng, Yu-Qiang, Wang, Wei-Jun, Shan, Yun-Feng, Cheng, Shu-Qun
Publicado 2021

Camrelizumab plus gemcitabine and oxaliplatin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observational retrospective study

por Zhang, Yu-Qing, Wang, Kang, Feng, Jin-Kai, Yuan, Lu-Yun, Liang, Chao, Xiang, Yan-Jun, Wang, Xu, Mao, Fei-Fei, Cheng, Shu-Qun
Publicado 2023

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

por Zhang, Xiu-Ping, Wang, Kang, Li, Nan, Zhong, Cheng-Qian, Wei, Xu-Biao, Cheng, Yu-Qiang, Gao, Yu-Zhen, Wang, Han, Cheng, Shu-Qun
Publicado 2017

AXL Overexpression in Tumor-Derived Endothelial Cells Promotes Vessel Metastasis in Patients With Hepatocellular Carcinoma

por Chai, Zong-Tao, Zhang, Xiu-Ping, Ao, Jian-Yang, Zhu, Xiao-Dong, Wu, Meng-Chao, Lau, Wan Yee, Sun, Hui-Chuan, Cheng, Shu-Qun
Publicado 2021

Comparison of different surgical interventions for hepatocellular carcinoma with bile duct tumor thrombus: a systematic review and meta-analysis

por Feng, Jin-Kai, Chen, Zhen-Hua, Wu, Yu-Xuan, Wang, Kang, Sun, Ju-Xian, Chai, Zong-Tao, Guo, Wei-Xing, Shi, Jie, Cheng, Shu-Qun
Publicado 2020

The effect of bile duct tumor thrombus on the long-term prognosis of hepatocellular carcinoma patients after liver resection: a systematic review and meta-analysis

por Feng, Jin-Kai, Wu, Yu-Xuan, Chen, Zhen-Hua, Sun, Ju-Xian, Wang, Kang, Chai, Zong-Tao, Shi, Jie, Guo, Wei-Xing, Cheng, Shu-Qun
Publicado 2020

Efficacy and Safety of Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma Associated with Bile Duct Tumor Thrombus: A Real-World Retrospecti...

por Feng, Jin-Kai, Sun, Ju-Xian, Liu, Zong-Han, Gu, Jing-Wen, Chen, Zhen-Hua, Liu, Chang, Guo, Wei-Xing, Shi, Jie, Cheng, Shu-Qun
Publicado 2021

Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma

por Wang, Kang, Guo, Wei xing, Li, Nan, Gao, Chun fang, Shi, Jie, Tang, Yu fu, Shen, Feng, Wu, Meng chao, Liu, Shan rong, Cheng, Shu qun
Publicado 2015

Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol

por Wang, Kang, Yu, Hong-Ming, Xiang, Yan-Jun, Cheng, Yu-Qiang, Ni, Qian-Zhi, Guo, Wei-Xing, Shi, Jie, Feng, Shuang, Zhai, Jian, Cheng, Shu-Qun
Publicado 2022

In-hospital Mortality after Surgical Resection in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus

por Zhang, Xiu-Ping, Gao, Yu-Zhen, Chen, Zhen-Hua, Wang, Kang, Cheng, Yu-Qiang, Guo, Wei-Xing, Shi, Jie, Zhong, Cheng-Qian, Zhang, Fan, Cheng, Shu-Qun
Publicado 2019

A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma

por Wu, Jun-Yi, Sun, Ju-Xian, Wu, Jia-Yi, Huang, Xiao-Xiao, Bai, Yan-Nan, Zeng, Yong-Yi, Zhang, Zhi-Bo, Cheng, Shu-Qun, Yan, Mao-Lin
Publicado 2021

NET1 promotes HCC growth and metastasis in vitro and in vivo via activating the Akt signaling pathway

por Chen, Zhen-Hua, Ni, Qian-Zhi, Zhang, Xiu-Ping, Ma, Ning, Feng, Jing-Kai, Wang, Kang, Li, Jing-Jing, Xie, Dong, Ma, Xing-Yuan, Cheng, Shu-Qun
Publicado 2021